Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

CCT Venues

Oct 12, 2022 2:00 PM - Oct 13, 2022 10:30 PM

Level 32, 40 Bank Street, London, E14 5NR, United Kingdom

Pharmacovigilance Strategies Workshop

Engage in the sharing of good practices between industry representatives and seek advice from regulators in this unique workshop

Session 2: Globalisation Of PSMF : Practical Implementation

Session Chair(s)

Francoise  Sillan, MD

Francoise Sillan, MD

EU1 UK QPPV

Ipsen, France

Willemijn  van der Spuij, MSc

Willemijn van der Spuij, MSc

Executive Director, WorldWide Patient Safety International, Europe

Switzerland

This session focusses on the PSMF requirements from a global perspective. With the expansion of PSMF, or similar, requirements, better understanding the landscape in which we operate will be beneficial to participants. Through the lens of various experts we will be looking at how varying global requirements impact the concept of the PV system and its description, its development and maintenance. The session will cover a deep dive into some of the PSMF requirements outside the EEA. We will explore the learnings to be taken from audit findings by looking at what trends have been observed and can be used as part of the global consideration and improvements. And the session will include a regulators view, what are the requirements and expectations specific to the UK for the PSMF. Why are these requirements so important.

The Q&A as part of this session will allow the participants to interact with the experts and discuss considerations for pragmatic ways of working for the PSMF in the global environment.

Speaker(s)

Sean  Burke, MSc

Global Perspective on The Implementation of the PSMF

Sean Burke, MSc

Merck , United Kingdom

Pharmacovigilance Lead, EEMEA

Aalaa  Afdal Mogheith, MPA, MPharm

National Authority (outside EU)

Aalaa Afdal Mogheith, MPA, MPharm

Egyptian Drug Authority (EDA), Egypt

Head of Pharmaceutical Vigilance, General Administrator

Melanie Weber Weber, MSc

Audit Perspective on the PSMF

Melanie Weber Weber, MSc

Pietrek Associates Gmbh, Germany

Pharmacovigilance Expert

Claire  Longman, MSc

MHRA Perspective

Claire Longman, MSc

Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom

Expert Pharmacovigilance Inspector

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.